Jimmy Che‐To Lai
机构：Chinese University of Hong Kong, Regend Therapeutics (China), University of Hong Kong · ORCID：0000-0002-5749-1598
发表论文 149 篇 · 总被引 1843 次 · h-index 23
代表论文
- Secular Trend in Glycaemic Management in Type 2 Diabetes Patients With and Without Cirrhosis Between 2000 and 2023: A Territory‐Wide Cohort Study (2026 · Alimentary Pharmacology & Therapeutics · 被引 2)
- Hepatic Steatosis and Low‐Density Lipoprotein Cholesterol Response After Statin Initiation: A Prospective Cohort Analysis (2026 · Journal of Gastroenterology and Hepatology)
- Global multicenter validation of noninvasive fibrosis assessment pathways in MetALD and ALD (2026 · Hepatology Communications)
- Artificial Intelligence and Generative Models in Hepatology: From Large Language Models to Digital Pathology in Liver Disease Diagnosis and Treatment (2026 · Clinical and Molecular Hepatology)
- Machine Learning Prediction of Liver Fibrosis in Patients with Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) (2026 · Clinical Gastroenterology and Hepatology)
- Long-Term Incidence of Hepatocellular Carcinoma After Hepatitis B Surface Antigen Seroclearance (2026 · Gastroenterology)